Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?

    loading  Checking for direct PDF access through Ovid

Abstract

Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, et al. Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med. 2016; 176(11):1662–1671.

Related Topics

    loading  Loading Related Articles